Aiml Resources (AIML) AI Stock Analysis

• Market Cap: C$10.16M
• Dividend Yield: N/A
• Average Volume (3M): 377.83K
• Price to Earnings (P/E): ―
• Beta (1Y): 1.65
• Revenue Growth: -64.23%
• EPS Growth: 18.42%
• Country: CA
• Employees: N/A
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Healthcare Information Services
• EPS (TTM): N/A
• Shares Outstanding: 253,987,750
• 10 Day Avg. Volume: 220,274
• 30 Day Avg. Volume: 377,826
• PEG Ratio: 0.07
• Price to Book (P/B): 4.95
• Price to Sales (P/S): 76.79
• P/FCF Ratio: -3.22
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 47 Neutral
• Price Target: C$0.04 ▼(-2.50% Downside)

Aiml Resources' overall stock score is primarily impacted by its poor financial performance and bearish technical indicators. However, positive corporate events provide some optimism, reflecting strategic expansions and technological advancements. The valuation remains unattractive due to negative profitability metrics.

Positive Factors

Low Debt Levels

Low debt levels provide financial flexibility and reduce the risk of insolvency, allowing AIML to invest in growth opportunities without significant financial strain.

Strategic Partnerships

These partnerships enhance AIML's market reach and product offerings, potentially driving long-term revenue growth and competitive advantage.

High Gross Profit Margin

A high gross profit margin indicates strong pricing power and cost efficiency at the product level, which can be leveraged to improve overall profitability if operational inefficiencies are addressed.

Negative Factors

Negative Cash Flows

Negative cash flows limit AIML's ability to invest in growth and cover operational expenses, posing a risk to long-term sustainability and financial health.

Declining Revenue Growth

Declining revenue growth suggests weakening market demand or competitive pressures, which could impact AIML's ability to scale and achieve profitability.

Operational Inefficiencies

Operational inefficiencies lead to profitability challenges, requiring AIML to streamline processes and reduce costs to improve financial performance.

Aiml Resources Business Overview & Revenue Model

Company Description

AI/ML Innovations Inc. operates in the digital healthcare business using artificial intelligence (AI) and machine learning (ML). It focuses on offering a patent-pending personal health monitoring and management system for caregivers, patients, and healthcare professionals to access and utilize data for enhance recovery outcomes and healthy living, as well as digital health software and wearable technologies. The company was formerly known as AIML Resources Inc. and changed its name to AI/ML Innovations Inc. in November 2020. AI/ML Innovations Inc. was incorporated in 2009 and is headquartered in Victoria, Canada.

How the Company Makes Money

AIML generates revenue through multiple key streams, including software licensing fees, subscription-based services, and consulting contracts. The company charges clients for access to its proprietary AI platforms, which are designed to improve data analysis and operational workflows. Additionally, AIML earns income by providing tailored consulting services to organizations looking to implement AI solutions, helping them to optimize their processes and achieve business goals. Strategic partnerships with technology providers and industry players also play a significant role in its revenue model, as these alliances enable AIML to expand its market reach and offer integrated solutions to customers.

Aiml Resources Financial Statement Overview

Summary

Aiml Resources faces significant financial challenges, with negative net profit margins, declining revenue growth, and substantial EBIT and EBITDA losses. The balance sheet shows financial instability with negative return on equity, and cash flow statements reveal liquidity issues with consistent negative operating and free cash flows.

Income Statement

Aiml Resources has faced significant challenges in its income statement, with negative net profit margins and declining revenue growth. The gross profit margin is high, but this is overshadowed by substantial EBIT and EBITDA losses, indicating operational inefficiencies. The company needs to address these issues to improve its financial health.

Balance Sheet

The balance sheet shows a relatively low debt-to-equity ratio, which is a positive sign of financial stability. However, the negative return on equity and fluctuating equity levels suggest underlying financial instability. Improving equity and asset management could enhance the company's financial position.

Cash Flow

The cash flow statement reveals consistent negative operating and free cash flows, indicating liquidity challenges. Despite a slight improvement in free cash flow growth, the company struggles to generate positive cash flow from operations, which is critical for sustainability.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	167.58K	167.31K	600.14K	487.50K	65.41K	0.00
Gross Profit	163.29K	162.81K	294.86K	466.01K	65.41K	0.00
EBITDA	-5.55M	-4.85M	-1.67M	-1.36M	-3.42M	-1.43M
Net Income	-6.14M	-4.59M	-3.29M	-1.42M	-3.17M	-2.73M
Balance Sheet
Total Assets	2.32M	3.41M	329.69K	1.51M	2.04M	3.59M
Cash, Cash Equivalents and Short-Term Investments	1.07M	2.00M	216.86K	14.56K	525.24K	3.49M
Total Debt	190.82K	198.19K	197.72K	859.98K	261.34K	320.29K
Total Liabilities	1.24M	855.77K	1.54M	1.79M	1.55M	1.51M
Stockholders Equity	1.12M	2.60M	-1.17M	-247.46K	1.08M	2.31M
Cash Flow
Free Cash Flow	-4.36M	-3.99M	-1.64M	-634.28K	-3.02M	-959.00K
Operating Cash Flow	-4.36M	-3.99M	-1.64M	-634.28K	-3.02M	-931.35K
Investing Cash Flow	1.11K	-1.15K	-325.98K	-210.64K	-1.14M	-11.38K
Financing Cash Flow	4.78M	5.78M	2.16M	374.37K	1.27M	4.17M

Aiml Resources Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.04
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Positive
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:AIML, the sentiment is Negative. The current price of 0.04 is above the 20-day moving average (MA) of 0.04, below the 50-day MA of 0.05, and below the 200-day MA of 0.06, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 24.17 is Positive, neither overbought nor oversold. The STOCH value of 50.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:AIML.

Aiml Resources Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
ADK	52 Neutral	C$31.58M	-6.50	―	―	-48.53%	-9.66%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
AIML	47 Neutral	C$10.16M	-1.17	-1143.80%	―	-64.23%	18.42%
CHS	44 Neutral	C$8.70M	-2.27	―	―	16.04%	-455.38%
UDOC	34 Underperform	C$16.41M	-2.86	―	―	―	48.94%
DMED	33 Underperform	C$6.55M	-4.72	―	―	―	-67.11%
NARA	29 Underperform	C$8.71M	-1.88	―	―	―	81.01%

Aiml Resources Corporate Events

NeuralCloud Partners with Cornerstone Physiotherapy for Athlete Performance Pilot

NeuralCloud Solutions Inc., a subsidiary of AI/ML Innovations Inc., has initiated a pilot collaboration with Cornerstone Physiotherapy to integrate its MaxYield™ and Insight360™ technologies into Cornerstone’s elite athlete performance program. This partnership aims to enhance athlete training by using AI-enhanced ECG signals to provide insights into cardiac performance, potentially expanding NeuralCloud’s reach into sports science and human performance markets.

NeuralCloud Expands AI ECG Technology into Equine Health with Equimetrics Partnership

NeuralCloud Solutions Inc., a subsidiary of AI/ML Innovations Inc., has signed a commercial agreement with Equimetrics to integrate its AI-driven ECG signal processing technology into Equimetrics’ equine cardiac monitoring platforms. This collaboration aims to enhance veterinary health and elite equine performance by providing reliable ECG data for better diagnostics and performance optimization, marking a significant expansion of NeuralCloud’s technology into the veterinary and performance health sectors.

Neural Cloud Launches AI-Driven Cardiac Care Pilot at SickKids

AI/ML Innovations Inc.’s subsidiary, Neural Cloud, has initiated a pilot project with The Hospital for Sick Children to evaluate its MaxYield™ platform in pediatric cardiac care. This collaboration aims to enhance early-stage detection of cardiac deterioration in children by applying advanced AI-based ECG signal processing. The project, led by Dr. Cedric Manlhiot, seeks to improve the accuracy and reliability of AI models in predicting cardiac complications, marking a significant step in developing responsible ECG tools for pediatric cardiology.

AI/ML Innovations Secures U.S. Patent for ECG Signal-Processing Technology

AI/ML Innovations Inc. has announced the granting of a U.S. patent for its core ECG signal-processing architecture, which enhances its competitive edge as it moves towards commercialization and regulatory approval. This patent solidifies AIML’s intellectual property position, supporting its strategies in cardiology, remote monitoring, telehealth, and clinical research applications, and underscores the company’s commitment to expanding its IP portfolio.

NeuralCloud Solutions Advances Cardiac Care in Jamaica with AI-Enabled Diagnostics

AI/ML Innovations Inc.’s subsidiary, NeuralCloud Solutions, has partnered with Lonacas Consultants to lead the regulatory submission for its CardioYield™ software in Jamaica. This collaboration is a strategic move to expand NeuralCloud’s presence in the Caribbean by providing affordable, high-quality cardiac diagnostics. The initiative aims to address the growing cardiovascular disease burden in Jamaica by introducing a cost-effective, AI-enhanced ECG monitoring solution. The CardioYield™ platform, combined with a wearable chest strap, promises to improve access to cardiac care, particularly in regions with limited diagnostic resources. This regulatory process is crucial for ensuring the technology’s compliance with local standards and its successful deployment across healthcare facilities in Jamaica.

AIML Innovations Launches AI-Powered ECG Pilot with Canadian Cardiology Clinic

AI/ML Innovations Inc. announced that its subsidiary, NeuralCloud Solutions, is launching a pilot program with a Canadian cardiology clinic to implement its AI-powered ECG analysis platform, CardioYield™. This initiative aims to enhance the accuracy and efficiency of Holter ECG analysis through advanced AI signal processing, potentially improving clinical workflows and diagnostic precision. The pilot will start with internal validation, followed by in-clinic testing, and aims for full integration pending regulatory clearance. This collaboration represents a significant step in AIML’s mission to deliver AI-driven healthcare solutions and could set a benchmark for AI-driven reporting improvements in cardiology.

AIML Innovations Launches Cardiac Care Pilot in Jamaica

AI/ML Innovations Inc.’s subsidiary, NeuralCloud Solutions, in collaboration with Heartdent Center Ltd., has launched a pilot project in Jamaica to advance cardiac care using their AI-powered platform, CardioYield™. This initiative aims to provide affordable, accurate, and scalable Holter diagnostics, addressing the urgent need for accessible cardiac diagnostics in Jamaica, where cardiovascular disease is a leading cause of death. The pilot project will evaluate the integration and operational impact of CardioYield™ in Heartdent Center’s practice, potentially setting new standards for patient-centered care and improving patient outcomes through timely and accurate diagnosis.

AIML Innovations Launches AI-Powered ECG Reporting Pilot with Toronto Heart Centre

AI/ML Innovations Inc.’s subsidiary, NeuralCloud Solutions, has launched a pilot program with the Toronto Heart Centre to test CardioYield™, an AI-powered Holter ECG reporting tool. The study aims to evaluate the efficiency and quality improvements in ECG analysis and reporting compared to current industry standards. This collaboration is expected to enhance clinical workflows, benefiting both clinicians and patients by potentially improving speed and diagnostic reliability.

AI/ML Innovations and BC Brain Wellness Program Launch Heart-Brain Connection Pilot

AI/ML Innovations Inc. has announced a pilot project in collaboration with the BC Brain Wellness Program to explore the heart-brain connection using its MaxYield ECG technology. This initiative aims to analyze cardiac responses in individuals with neurological conditions during exercise, potentially uncovering insights into the relationship between heart activity and brain health. The project marks an important step in expanding AIML’s technology into neurology, with implications for future clinical research and improved care through interdisciplinary AI applications.

AI/ML Innovations Inc. Closes Oversubscribed Private Placement and Extends Warrant Expiry

AI/ML Innovations Inc. announced the successful closing of an oversubscribed private placement, raising $2,128,595, exceeding its initial target of $1,550,000. The funds will be used for general working capital, and the placement involved significant insider participation, constituting a related party transaction under regulatory guidelines. Additionally, the company extended the expiry date of existing share purchase warrants from a previous financing round, reflecting its strategic financial management.